The purpose of this action is to purchase xenium prime 5K human pan tissue and pathways assay kits.

Ended Awarded Last action

Contract number
75N95A25F00001
Awardee
Awarding agency
Obligated
$22,599

Award facts

Contract value 100% obligated
$22,599.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6640 Laboratory Equipment And Supplies
Set-aside
No set-aside
Competition
Competed under SAP · 6 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Pleasanton, CA 94588, USA

Award details come from SAM.gov/FPDS.

About this award

The National Institute of Neurological Disorders and Stroke issued a BPA call to 10X Genomics, Inc. on August 26, 2025, with a ceiling value of $22,599 for Xenium Prime 5K Human Pan Tissue and Pathways Assay Kits. The call carries a firm fixed price and no set-aside. Place of performance is Pleasanton, California. Ultimate completion is August 25, 2026.

Quick answers

Who was awarded contract 75N95A25F00001?

75N95A25F00001 was awarded to 10X Genomics, Inc. by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on August 26, 2025.

How much is contract 75N95A25F00001 worth?

The government has obligated $22,599 on 75N95A25F00001.

Is contract 75N95A25F00001 an order under another contract?

Yes. 75N95A25F00001 is a BPA call under 75N98022A00032, a blanket purchase agreement.

Was contract 75N95A25F00001 competed?

The extent of competition for 75N95A25F00001 was competed under sap. The government received 6 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award